Literature DB >> 10570319

Inactivation of NF-kappaB by EBV BZLF-1-encoded ZEBRA protein in human T cells.

D H Dreyfus1, M Nagasawa, J C Pratt, C A Kelleher, E W Gelfand.   

Abstract

We have previously shown that the EBV ZEBRA protein (also denoted EB1, Z, or Zta) encoded by the BZLF open reading frame is expressed in primary human thymocytes and in human T lymphoblastoid cell lines infected by EBV. Expression of EBV-encoded gene products in T lymphocytes could contribute to viral pathogenesis during acute EBV infection as well as in individuals coinfected with EBV and HIV. HPB-ALL and Jurkat T lymphoblastoid cell lines transiently and stably expressing ZEBRA were characterized in this work. Expression of ZEBRA protein in human T lymphoblastoid cells was associated with decreased expression of an NF-kappaB reporter gene, altered expression of the NF-kappaB p50 protein subunit, and decreased DNA binding by components of NF-kappaB. These observations suggest that inactivation of NF-kappaB transcription by ZEBRA in EBV-infected T cells may be a novel mechanism of viral pathogenesis analogous in part to over-expression of the endogenous cytoplasmic inhibitor of NF-kappaB, IkappaBalpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins.

Authors:  Jillian A Bristol; Amanda R Robinson; Elizabeth A Barlow; Shannon C Kenney
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

Review 4.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.

Authors:  Sinéad Keating; Stuart Prince; Matthew Jones; Martin Rowe
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 6.  NF-kappaB and virus infection: who controls whom.

Authors:  M Gabriella Santoro; Antonio Rossi; Carla Amici
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  Kaposi's sarcoma: a computational approach through protein-protein interaction and gene regulatory networks analysis.

Authors:  Aubhishek Zaman; Md Habibur Rahaman; Samsad Razzaque
Journal:  Virus Genes       Date:  2012-12-25       Impact factor: 2.332

8.  Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.

Authors:  David H Dreyfus; Yang Liu; Lucy Y Ghoda; Joseph T Chang
Journal:  Virol J       Date:  2011-09-05       Impact factor: 4.099

9.  Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.

Authors:  David H Dreyfus; Masayuki Nagasawa; Erwin W Gelfand; Lucy Y Ghoda
Journal:  BMC Immunol       Date:  2005-06-21       Impact factor: 3.615

Review 10.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.